NEU-111

N/A

Report date: 2024/12/13 15:38:35

NME

Base Information

Drug NameNEU-111

Drug Alias NameNEU-111

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase 2 inhibitors

TargetsTyrosine-protein kinase 2

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew Zealand

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNeuron23 Inc

China Registration ClassN/A

Active CompaniesNeuron23 Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A